For decades, hormone replacement therapies carried warnings that they increased the risk of cancer and dementia. Now, that ...
The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...
Sarepta must also run a post-marketing study for Elevidys to better assess the risk of serious liver injury in patients dosed ...
FDA added a boxed warning to Elevidys after two pediatric deaths and imposed stricter monitoring rules. ・Use of gene therapy ...
Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...
Hormone therapy helps women. Now the FDA is reversing its warning on estrogen treatment which could change treatemtn for ...
The Food and Drug Administration says it will remove a long-standing warning from hormone-based drugs used to treat menopause ...
In San Francisco, a growing number of Latinos who work physically demanding jobs are turning to supplements like Artri Ajo ...
The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.
The FDA recently announced it would remove “misleading” black box warnings for drugs that use hormones to treat menopause.
Sarepta Therapeutics Inc.’s controversial gene therapy for a rare muscle condition will remain available in the US with a ...
FDA seeks to lift “black box" warnings from menopause hormone therapy, citing evidence that benefits outweigh risks.